Edoxaban
Edoxaban comes in 13 pill versions in our database, in 3 strengths, from 5 manufacturers. Check the imprint to tell them apart.
Edoxaban pill images
15 mg 3 pills
- DSC L15 Edoxaban Tosylate 15 mg Orange, round, 7 mm Used for blood clots in the veins and blood clots in the lungs
- EX 15 Edoxaban Tosylate Monohydrate 15 mg Orange, round Used for blood clots in the veins and blood clots in the lungs
- TV 15 Edoxaban Tosylate Monohydrate 15 mg Orange, round Used for blood clots in the veins and blood clots in the lungs
30 mg 5 pills
- DSC L30 Edoxaban Tosylate 30 mg Pink, round, 9 mm Used for blood clots in the veins and blood clots in the lungs
- EX 30 Edoxaban Tosylate Monohydrate 30 mg Pink, round Used for blood clots in the veins and blood clots in the lungs
- TV 30 Edoxaban Tosylate Monohydrate 30 mg Pink, round Used for blood clots in the veins and blood clots in the lungs
- EX 30 Edoxaban Tosylate Monohydrate 30 mg Pink, round Used for blood clots in the veins and blood clots in the lungs
- E30 JP Edoxaban Tosylate Monohydrate 30 mg Pink, round Used for blood clots in the veins and blood clots in the lungs
60 mg 5 pills
- DSC L60 Edoxaban Tosylate 60 mg Yellow, round, 11 mm Used for blood clots in the veins and blood clots in the lungs
- EX 60 Edoxaban Tosylate Monohydrate 60 mg Yellow, round Used for blood clots in the veins and blood clots in the lungs
- TV 60 Edoxaban Tosylate Monohydrate 60 mg Yellow, round Used for blood clots in the veins and blood clots in the lungs
- EX 60 Edoxaban Tosylate Monohydrate 60 mg Yellow, round Used for blood clots in the veins and blood clots in the lungs
- E60 JP Edoxaban Tosylate Monohydrate 60 mg Yellow, round Used for blood clots in the veins and blood clots in the lungs
What is Edoxaban used for?
Edoxaban is used for blood clots in the veins and blood clots in the lungs.
- Medicine type
- Blood thinner (factor Xa inhibitor)
Official uses from the US prescribing label
Reduction in the Risk of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation
SAVAYSA is indicated to reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF).
Limitation of Use for NVAF
SAVAYSA should not be used in patients with CrCL > 95 mL/min because of an increased risk of ischemic stroke compared to warfarin.
Treatment of Deep Vein Thrombosis and Pulmonary Embolism
SAVAYSA is indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant.
From the FDA-approved label on DailyMed (published Jul 14, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.